Work

Figure S5 from RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

Year: 2025

Type: other

Abstract: Figure S5. Combination activity of batoprotafib with temuterkib in multicell-type tumor spheroids.

DOI: 10.1158/2767-9764.30304687

Authors: Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, Raymond G. Fox, Samantha B. Kemp, Poorva Juneja, Joel Morris, Melinda G. Hollingshead, Naoko Takebe, James H. Doroshow, Beverly A. Teicher

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4414987783

Cites:

Cited by:

Related to: